Inari Medical, Inc. (NARI) Tops Q3 EPS by 4c

Inari Medical, Inc. (NASDAQ: NARI) reported Q3 EPS of $0.05, $0.04 better than the analyst estimate of $0.01. Revenue for the quarter came in at $126.4 million versus the consensus estimate of $121.92 million.

For earnings history and earnings-related data on Inari Medical, Inc. (NARI) click here.

You May Also Be Interested In

• SanDisk stock target lifted by Citi on continued demand strength
• BlackBerry (BB) Tops Q1 EPS by 1c, Offers Guidance
• Travere Therapeutics (TVTX) PT Raised to $65 at Guggenheim